Research Article

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use

Table 2

Demographic and clinical characteristics of subjects offered 17-Hydroxyprogesterone caproate (17-OHP-C).

Patient characteristicReceived 17-OHP-CDeclined 17-OHP-C value
( ) ( )

Maternal age (mean years ± SD)27.7 ± 4.827.5 ± 5.8.87
% African-American54.2 (26/48)67.6 (23/34).22
% Single64.6 (31/48)61.8 (21/34).79
% Medicaid Insurance77.1 (37/48)67.6 (23/34).34
% Years school ≤1260.4 (26/43)70.0 (21/30).40
% Preeclampsia or gestational hypertension (current pregnancy)19.6 (9/46)14.7 (5/34).76
% Cerclage (all types)12.7 (6/47)11.7 (4/34)1.00
Multiple (>1) prior PTB37.5 (18/48)41.2 (14/34).74
Etiology of index preterm birth due to preterm labor55.3 (26/47)61.8 (21/34).56
Interval term delivery since preterm birth4.2 (2/48)17.6 (6/34).10
Cesarean section (current pregnancy)28.3 (13/46)21.9 (7/32).53
Birth weight (mean gm ± SD) .47
Gestational age of most recent preterm delivery 28.7 (25.3–32.8)34.0 (28.3–36.0).02
Gestational age of earliest preterm delivery 28.0 (24.3–32.0)*32.0 (25.2–34.0)*.11
Gestational age at delivery of current gestation 37.0 (35.2–38.4)*37.2 (35.2–39.2)*.39

Data presented as median and IQR.